Mylotarg and blood lactate dehydrogenase increased Patient Reports February 10, 2010

Mylotarg Side Effects Report #4937095-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, febrile neutropenia. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with MODACIN, SULPERAZON, TIENAM, CIPROFLOXACIN HYDROCHLORIDE, MEROPEN, PRODIF, POLYMYXIN B SULPHATE. Patient recovered.

Mylotarg Side Effects Report #5206008-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: 9 MG/M2 1X PER 1 DAY; INTRAVENOUS DRIP. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5105263-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4977021-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5050786-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood creatinine decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CEFTAZIDIME, ANTITHROMBIN III, NORMAL IMMUNOGLOBULIN, AMIKACIN SULPHATE, AMIKACIN SULPHATE, MEROPEN. Patient died.

Mylotarg Side Effects Report #5080806-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 28, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, disease progression, gastrointestinal haemorrhage, hypocalcaemia, neutrophil count decreased, oral intake reduced, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with AMLODIPINE BESYLATE, LONGES, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4974424-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, hypocalcaemia, neutrophil count decreased, platelet count decreased, pyrexia, unevaluable event. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, LISINOPRIL, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5203361-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, dyspepsia, febrile neutropenia, fibrin degradation products increased, hypersensitivity, hypertension, hypoalbuminaemia, hypokalaemia. Mylotarg dosage: SEE IMAGE MG/M^2 1X PER 1 DAY; 9 MG/M^2 1X PER 1 DAY. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5086082-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent, sinusitis

, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, RABEPRAZOLE, NEUTROGIN. Patient died.

Mylotarg Side Effects Report #5046899-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent, sinusitis

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, disseminated intravascular coagulation, gamma-glutamyltransferase increased, glucose urine present. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, LEVOFLOXACIN, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5202114-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #5109798-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count decreased, blood albumin decreased, blood lactate dehydrogenase increased, blood urea decreased, c-reactive protein increased, fibrin degradation products increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with FIRSTCIN, TIENAM, OMEGACIN, FUNGUARD, PRODIF, FARESTON, RISPERDAL. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5110872-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 06, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, CRAVIT, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5158276-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5197491-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count decreased, blood lactate dehydrogenase increased, blood urea decreased, fibrin degradation products increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, myeloid leukaemia, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with FIRSTCIN, TIENAM, OMEGACIN, FUNGUARD, PRODIF, FARESTON, RISPERDAL. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4914259-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 07, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, cellulitis

, chills, disease progression, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient died.

Mylotarg Side Effects Report #4979710-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 06, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, cellulitis

, chills, malignant neoplasm progression, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.

Mylotarg Side Effects Report #4992456-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 19, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, infection

, liver disorder, multi-organ failure, renal disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLACINON. Patient died.

Mylotarg Side Effects Report #5065809-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 18, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chills, febrile neutropenia, fibrin degradation products increased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with RIZE, NITRAZEPAM, LEVOFLOXACIN, FAMOTIDINE, ITRACONAZOLE. Patient recovered.

Mylotarg Side Effects Report #5133057-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chills, febrile neutropenia, fibrin degradation products increased, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with RIZE, NITRAZEPAM, LEVOFLOXACIN, FAMOTIDINE, ITRACONAZOLE. Patient recovered.

Mylotarg Side Effects Report #5053133-3
Mylotarg side effect was reported by a Health Professional from JAPAN on June 29, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ZOFRAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4958936-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent, chloroma and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, fibrin degradation products increased, gamma-glutamyltransferase increased, gastrointestinal haemorrhage, performance status decreased. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ORGARAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5019634-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4837022-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2005. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, disease progression, hepatomegaly, leukaemia, pyrexia, sepsis

, venoocclusive liver disease. Mylotarg dosage: A SINGLE 6MG/M2 DOSE. During the same period patient was treated with CARBENIN, ISEPACIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ALBUMIN, ANTITHROMBIN III. Patient recovered.

Mylotarg Side Effects Report #5151889-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cellulitis

, disseminated intravascular coagulation, dysphagia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, SULFAMETHOXAZOLE, ALLORINE, VFEND. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5085439-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, hepatic function abnormal, prothrombin time prolonged, pyrexia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.

Mylotarg Side Effects Report #5019629-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.

Mylotarg Side Effects Report #5217067-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex

, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5220629-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex

. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4839607-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4867132-5
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4906948-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 26, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9MG/M2 DOSE. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4917046-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood stem cell transplant failure, bone marrow failure, c-reactive protein increased, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5080715-5
Mylotarg side effect was reported by a Health Professional from JAPAN on July 28, 2006. Male patient, 23 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, febrile neutropenia, liver disorder, lymphadenitis, nausea

, neutrophil count decreased. Mylotarg dosage: A SINGEL 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with SELBEX, GASMOTIN, TOSUFLOXACIN TOSILATE, DIFLUCAN, FIRSTCIN, MEROPEN, TARGOCID, PAZUCROSS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5259682-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 02, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, performance status decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FUNGUARD, MEROPEN, ISEPACIN. Patient recovered.

Mylotarg Side Effects Report #5263982-4
Mylotarg side effect was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, sepsis

. Mylotarg dosage: unknown. During the same period patient was treated with LIPOVAS, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, ENOCITABINE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5294652-4
Mylotarg side effect was reported by a Physician from JAPAN on Apr 03, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, pneumonia

. Mylotarg dosage: unknown. During the same period patient was treated with GASTER, DIFLUCAN, LEVOFLOXACIN, LASIX, SELBEX. Patient died on 03/27/2007.

Mylotarg Side Effects Report #5303031-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hyperlipidaemia, diabetes mellitus, constipation

, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, agranulocytosis, ascites, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, cholestasis. Mylotarg dosage: unknown. During the same period patient was treated with LIPITOR, ACTOS, MAGNESIUM OXIDE, HUMULIN, BACTRIM, POLYMYXIN B SULPHATE, FUNGIZONE. Patient was hospitalized. Patient died on 01/18/2007.

Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5315902-1
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5318951-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 27, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent, sepsis

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, performance status decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FUNGUARD, MEROPEN, ISEPACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5324992-1
Mylotarg side effect was reported by a Physician from JAPAN on May 07, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, haematuria, hypokalaemia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ITRACONAZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5376161-7
Mylotarg side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5410045-0
Mylotarg side effect was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent, interstitial lung disease, gingivitis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, body temperature decreased, gingivitis, interstitial lung disease, liver disorder, pyrexia, toxic skin eruption. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, AMINOACETIC ACID, DALACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5420780-6
Mylotarg side effect was reported by a Physician from JAPAN on Aug 17, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5447251-5
Mylotarg side effect was reported by a Physician from JAPAN on Sept 06, 2007. Female patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent, interstitial lung disease, gingivitis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, body temperature decreased, gingivitis, interstitial lung disease, liver disorder, pyrexia, toxic skin eruption. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, AMINOACETIC ACID, DALACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5481191-0
Mylotarg side effect was reported by a Physician from JAPAN on Sept 28, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, blood uric acid decreased, c-reactive protein increased, condition aggravated, febrile neutropenia, gastrointestinal haemorrhage, haematemesis. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5507775-9
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, pneumonia

, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5524941-7
Mylotarg side effect was reported by a Physician from UNITED STATES on Nov 17, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, febrile neutropenia, haematemesis, haematuria, hypokalaemia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient died on 05/01/2007.

Mylotarg Side Effects Report #5636498-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood lactate dehydrogenase increased, blood uric acid increased, disease progression, febrile neutropenia, hyperchloraemia, hyperkalaemia, hypernatraemia, hypoproteinaemia. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ZYLORIC, LASIX, ITRIZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5645621-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, PARIET, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #5674263-9
Mylotarg side effect was reported by a Physician from JAPAN on Mar 13, 2008. Male patient, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, pneumonia fungal. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ITRACONAZOLE. Patient died on 03/27/2007.

Mylotarg Side Effects Report #5708677-5
Mylotarg side effect was reported by a Physician from JAPAN on Apr 08, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood uric acid increased, febrile neutropenia, hyperchloraemia, hyperkalaemia, hypernatraemia, hypoproteinaemia, jaundice

, lymphocyte count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, LASIX, ITRIZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5797024-9
Mylotarg side effect was reported by a Physician from JAPAN on June 23, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #5800406-X
Mylotarg side effect was reported by a Physician from JAPAN on June 25, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood uric acid increased, febrile neutropenia, hyperchloraemia, hyperkalaemia, hypernatraemia, hypoproteinaemia, jaundice

, lymphocyte count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, LASIX, ITRIZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5863189-3
Mylotarg side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, COTRIM, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, PURSENNID. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #6137719-0
Mylotarg side effect was reported by a Physician from JAPAN on Mar 26, 2009. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, cardiac failure congestive, depression

, disseminated intravascular coagulation, herpes zoster, neutrophil count decreased, post herpetic neuralgia, retinal haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, BAKTAR, MINOCYCLINE, DIFLUCAN, MEROPEN, FUNGUARD, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #5010988-6
Mylotarg side effect was reported by a Health Professional from JAPAN on May 15, 2006. Female patient was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, acute myeloid leukaemia recurrent, anaemia, blood lactate dehydrogenase increased, bone pain, chills, diarrhoea, disseminated intravascular coagulation, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with FUNGIZONE, POLYMYXIN B SULPHATE, ALLOID, BACTRIM, BIOFERMIN R, TIENAM, DAUNORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5113917-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, disease progression, myeloblast count increased, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE. Patient recovered.

Mylotarg Side Effects Report #5042462-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, malignant neoplasm progression, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE, FIRSTCIN, CEFPIRAMIDE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5074408-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, febrile neutropenia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN, ALLOPURINOL, DIFLUCAN. Patient recovered.

Mylotarg Side Effects Report #5134042-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, disease progression, eating disorder

, febrile neutropenia, hyperuricaemia, hypoproteinaemia, infection

, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FOSMICIN S, MAXIPIME, NIZATIDINE, SUCRALFATE, LASIX, DAUNORUBICIN HYDROCHLORIDE, ENOCITAMINE. Patient recovered.

Mylotarg Side Effects Report #5199525-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, eating disorder

, febrile neutropenia, hyperuricaemia, hypoproteinaemia, infection

, infusion related reaction, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FOSMICIN S, MAXIPIME, NIZATIDINE, SUCRALFATE, LASIX, DAUNORUBICIN HYDROCHLORIDE, ENOCITABINE. Patient recovered.

Mylotarg Side Effects Report #5025982-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 30, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN. Patient recovered.

Mylotarg Side Effects Report #4748600-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 05, 2005. Female patient, 76 years of age, weighting 104.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood creatinine increased, blood lactate dehydrogenase increased, blood uric acid increased, febrile neutropenia, haemoglobin decreased, hypoxia, platelet count decreased, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with ALLOPURINOL, HYDROXYUREA. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5041711-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Female patient, 76 years of age, weighting 104.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea decreased, blood uric acid increased, crepitations, febrile neutropenia, haemoglobin decreased, hypoxia, platelet count decreased, tumour lysis syndrome. Mylotarg dosage: UNK; 13.4 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5088633-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, 75 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, cardio-respiratory arrest, fluid overload, haematocrit decreased, haemoglobin decreased, hypoglycaemia, hypotension. Mylotarg dosage: 18 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with INSULIN HUMULIN, LASIX, LOPRESSOR, SYNTHROID, PREMARIN, GLIPIZIDE, ACYCLOVIR. Patient died on 05/18/2002.

Mylotarg Side Effects Report #5073616-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood alkaline phosphatase increased, blood calcium decreased, blood chloride increased, blood creatine increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood phosphorus decreased, blood potassium decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4897213-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 18, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, febrile neutropenia, glucose urine present, hypertension. Mylotarg dosage: 9 MG/M^2 1 X PER 1 DAY, INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with MERCAPTOPURINE, CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.

Mylotarg Side Effects Report #4976163-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, condition aggravated, febrile neutropenia, glucose urine present, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.

Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant

, chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.

Mylotarg Side Effects Report #4616368-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 07, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, pyrexia, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient recovered.

Mylotarg Side Effects Report #4627225-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4631234-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis, international normalised ratio increased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, AMBIEN, TYLENOL, ZOSYN, GENTAMICIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949629-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4959814-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, red blood cell count decreased, sepsis

. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with FAMOTIDINE, PANTOSIN, MAGNESIUM OXIDE, LASIX, KYTRIL, LOXONIN, MUCOSTA. Patient recovered.

Mylotarg Side Effects Report #4962833-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, febrile neutropenia, herpes zoster, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, GRAVIT, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5032005-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5223121-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex

. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ISEPACIN, CLINDAMYCIN PHOSPHATE, NEUPOGEN, BAKTAR, MEROPEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5103248-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Aug 28, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex

. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, SULFAMETHOXAZOLE, VFEND, MEROPEN, ISEPACIN, CLINDAMYCIN PHOSPHATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4998572-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 26, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia, sinusitis

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, fibrin d dimer increased, gamma-glutamyltransferase increased, haemoglobin decreased, hypoalbuminaemia, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CRAVIT, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5073159-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.

Mylotarg Side Effects Report #5106489-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, dizziness

, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.

Mylotarg Side Effects Report #5119380-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.

Mylotarg Side Effects Report #4867672-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2005. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood albumin decreased, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopneumonia, cardiopulmonary failure. Mylotarg dosage: 9 MG/M(2) (DOSE: 15 MG], INTRAVENOUS. During the same period patient was treated with HYDREA. Patient was hospitalized. Patient died on 06/13/1999.

Mylotarg Side Effects Report #4863969-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE. Patient died.

Mylotarg Side Effects Report #4867683-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cells present, blood lactate dehydrogenase increased, disease progression, febrile neutropenia, leukopenia, nausea

, thrombocytopenia. Mylotarg dosage: 9 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4869686-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M 2 1X PER 1 DAY. Patient died.

Mylotarg Side Effects Report #4678772-0
Mylotarg side effect was reported by a Physician from on May 18, 2005. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory failure, band neutrophil count decreased, blast cell count increased, blood lactate dehydrogenase increased, blood sodium increased, chills, convulsion, dialysis

, haematocrit decreased. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ANTIBIOTICS. Patient was hospitalized. Patient died on 05/10/2005.

Mylotarg Side Effects Report #4784249-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 23, 2005. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory failure, blast cell count increased, blood lactate dehydrogenase increased, chills, convulsion, dialysis

, haemolytic uraemic syndrome, hypertension, hypotension. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ANTIBIOTICS. Patient was hospitalized. Patient died on 05/10/2005.

Mylotarg Side Effects Report #4949626-7
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 07, 2006. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory failure, blast cell count increased, blood lactate dehydrogenase increased, blood sodium increased, chills, convulsion, dialysis

, haemoglobin decreased, haemolytic uraemic syndrome. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ANTIBIOTICS. Patient was hospitalized. Patient died on 05/10/2005.

Mylotarg Side Effects Report #4947722-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 203.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chills, febrile neutropenia, infusion related reaction, localised oedema, mental status changes, muscle spasms. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, ALLEGRA, ALLOPURINOL, REGLAN, BENADRYL, DECADRON, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5113466-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood lactate dehydrogenase increased, cardiac failure congestive, condition aggravated, haemoglobin decreased, interstitial lung disease, malignant neoplasm progression, performance status decreased, red blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ITRACONAZOLE, CIPROXAN, ALLOPURINOL, DIOVAN, LANSOPRAZOLE, SELBEX, MAGNESIUM OXIDE, DEXTROMETHORPHAN HYDROBROMIDE. Patient recovered.

Mylotarg Side Effects Report #5053178-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient, 55 years of age, weighting 194.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, malignant neoplasm progression, weight increased. Mylotarg dosage: 14.85 MG 1X PER 1 DAY; INTRAVENOUS. Patient died on 01/07/2006.

Mylotarg Side Effects Report #4952736-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2004. Male patient, 55 years of age, weighting 301.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, bacterial sepsis, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, blood lactate dehydrogenase increased, bone marrow failure, cholelithiasis. Mylotarg dosage: 22.5 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 05/04/2003.

Mylotarg Side Effects Report #5041835-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 51 years of age, weighting 106.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, dyspnoea, haemangioma of liver. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ZYPREXA, ZOLOFT, ACYCLOVIR, DIFLUCAN, LEVAQUIN, PROGRAF, CYTARABINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5624965-5
Mylotarg side effect was reported by a Physician from JAPAN on Feb 07, 2008. Female patient, 50 years of age, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hypokalaemia, neutrophil count decreased, platelet count decreased, pneumonia

, sepsis

, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with REBAMIPIDE, VFEND, MEROPEN, ARBEKACIN, RANITIDINE HYDROCHLORIDE. Patient died on 03/07/2007.

Mylotarg Side Effects Report #5683019-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 50 years of age, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia

, sepsis

, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with REBAMIPIDE, VFEND, MEROPEN, ARBEKACIN, RANITIDINE HYDROCHLORIDE. Patient died on 03/07/2007.

Mylotarg and blood lactate dehydrogenase increased

SideEffects101.com

Mylotarg and blood lactate dehydrogenase increased Patient Reports February 10, 2010

side effects of Mylotarg